Intellia Therapeutics, Inc. - 8-K Filing
Intellia Therapeutics presents commercial readiness and regulatory timeline for lonvo-z in hereditary angioedema (HAE) treatment.
Tickers: $NTLA
More Regulatory news
- Apogee Acquisition Corp - 10-Q Filing
- CoJax Oil & Gas Corp - 10-Q Filing
- AMAZE HOLDINGS, INC. - 10-Q Filing
- Enhanced Group Inc. - 10-Q Filing
- Cingulate Inc. - 8-K Filing
- Nuo Therapeutics, Inc. - 10-Q Filing
- EDGEWELL PERSONAL CARE Co - 10-K Filing
- Flux Power Holdings, Inc. - 8-K Filing
- Pasithea Therapeutics Corp. - 10-Q Filing
- Datavault AI Inc. - 8-K Filing